1. Adachi E, Nagai E, Saito M, Yotsuyanagi H. et al. Anti-spike protein antibody titer at the time of breakthrough infection of SARS-CoV-2 omicron. J Infect Chemother. 2022 Apr 1:S1341-321X(22)00100-3. doi: 10.1016/j.jiac.2022.03.021. Online ahead of print.
2. Mizutani T, Ishizaka A, Kawaoka Y, Yotsuyanagi H. et al. Correlation Analysis between Gut Microbiota Alterations and the Cytokine Response in Patients with Coronavirus Disease during Hospitalization. Microbiol Spectr. 2022 Mar 7:e0168921. doi: 10.1128/spectrum.01689-21. Online ahead of print.
3. Kawaoka Y, Uraki R, Kiso M, Yotsuyanagi H, et al. Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2. Res Sq. 2022 Feb 24:rs.3.rs-1375091. doi: 10.21203/rs.3.rs-1375091/v1. Preprint.
4. Yoshimi K, Takeshita K, Yotsuyanagi H, Kawaoka Y, Mashimo T. et al. CRISPR-Cas3-based diagnostics for SARS-CoV-2 and influenza virus. iScience. 2022 Feb 18;25(2):103830. doi: 10.1016/j.isci.2022.103830. Epub 2022 Jan 30. PMID: 35128347; PMCID: PMC8801231.
5. Takashita E, Kinoshita N, Yotsuyanagi H, Kawaoka Y. et al. Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant. N Engl J Med. 2022 Jan 26:NEJMc2119407. doi: 10.1056/NEJMc2119407. Epub ahead of print. PMID: 35081300; PMCID: PMC8809508.
6. Adachi E, Saito M, Nagai H, Yotsuyanagi H. et al. Transient depletion of T cells during COVID-19 and seasonal influenza in people living with HIV. J Med Virol. 2022 Jan 2. doi: 10.1002/jmv.27543. Epub ahead of print. PMID: 34978090.
7. Halfmann PJ, Kuroda M, Maemura T, Kawaoka Y, et al. Efficacy of vaccination and previous infection against the Omicron BA.1 variant in Syrian hamsters. Cell Rep. 2022 Apr 19;39(3):110688. doi: 10.1016/j.celrep.2022.110688. Epub 2022 Mar 28.
8. DeGrace MM, Ghedin E, Kawaoka Y, et al. Defining the risk of SARS-CoV-2 variants on immune protection. Nature. 2022 Mar 31. doi: 10.1038/s41586-022-04690-5. Online ahead of print.
9. Fujii T, Hagihara M, Yamayoshi S, Kawaoka Y et al. Anti-SARS CoV-2 IgG in COVID-19 Patients with Hematological Diseases: A Single-center, Retrospective Study in Japan. Intern Med. 2022 Mar 26. doi: 10.2169/internalmedicine.9209-21. Online ahead of print
10. Pattinson D, Jester P, Guan L, Y, Kawaoka Y et al. A Novel Method to Reduce ELISA Serial Dilution Assay Workload Applied to SARS-CoV-2 and Seasonal HCoVs. Viruses. 2022 Mar 9;14(3):562. doi: 10.3390/v14030562.